Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US counties, 2006-2009

Clinical Infectious Diseases

Volumn 53, Issue 3, 2011, Pages 245-253

  Payne, Daniel C ^a   Staat, Mary Allen ^b   Edwards, Kathryn M ^c   Szilagyi, Peter G ^d   Weinberg, Geoffrey A ^d   Hall, Caroline B ^d   Chappell, James ^c   Curns, Aaron T ^a   Wikswo, Mary ^a   Tate, Jacqueline E ^a   Lopman, Benjamin A ^a   Parashar, Umesh D ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CHILD; CHILD HOSPITALIZATION; CONTROLLED STUDY; DIARRHEA; GASTROENTERITIS; HEALTH SURVEY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; ROTAVIRUS INFECTION; SCHOOL CHILD; UNITED STATES; VACCINATION; VIRUS IDENTIFICATION; VOMITING;

CHILD, PRESCHOOL; DIARRHEA; GASTROENTERITIS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; UNITED STATES;

EID: 79960786384     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir307     Document Type: Article

References (23)

1. Malek MA, Curns AC, Holman RC, et al. Diarrhea- and rotavirusassociated hospitalizations among children less than 5 years of age; United States, 1997-2000. Pediatrics 2006; 117:1887-1892. (Pubitemid 46071230)
2. Payne DC, Staat MA, Edwards KM, et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics 2008; 122:1235-1243.
3. Staat MA, Azimi PH, Berke T, et al. Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J 2002; 21:221-227. (Pubitemid 34214139)
4. Rodriguez WJ, Kim HW, Brandt CD, et al. Rotavirus gastroenteritis in the Washington, DC, area: incidence of cases resulting in admission to the hospital. Am J Dis Child 1980; 134:777-779. (Pubitemid 10046513)
5. Widdowson MA, Meltzer MI, Xang X, et al. Cost effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics 2007; 119:684-697. (Pubitemid 46556667)
6. Widdowson MA, Meltzer M. Update on cost-effectiveness of rotavirus vaccination in the United States. Atlanta, GA: Advisory Committee on Immunization Practices, 2008.
7. Centers for Disease Control and Prevention. Prevention of rotavirus gastroenteritis among infants and children: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2009; 58:1-26.
8. RotaTeq (rotavirus vaccine, live, oral, pentavalent) [package insert]. Rockville, MD: Merck; 2011.
9. Payne DC, Szilagyi PG, Staat MA, et al. Secular variation in US rotavirus disease rates and serotypes-Implications for assessing the rotavirus vaccination program. Pediatr Infect Dis J 2009; 28:948-953.
10. Iwane MK, Edwards KM, Szilagyi PG, et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 2004; 113:1758-1764. (Pubitemid 38697988)
11. Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med 2006; 355:21-30.
12. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009; 360: 588-598.
13. Staat MA, Payne DC, Donauer S, et al. Effectiveness of pentavalent rotavirus vaccine against severe disease. Pediatrics 2011; in press
14. Payne DC, Szyilagyi PG, Staat MA, et al. Corrected 2007 rotavirus hospitalization rates. Pediatr Infect Dis J 2010; 29:287-288.
15. Tate JE, Panozzo CA, Payne DC, et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics 2009; 124:465-471.
16. Tate JE, Mutuc JD, Panozzo CA, et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J 2011; 30(Suppl 1):S30-S34.
17. Tate JE, Cortese MM, Payne DC, et al. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J 2011; 30(Suppl 1): S56-S60.
18. Centers for Disease Control and Prevention. Rotavirus vaccination coverage among infants aged 5-months-immunization information system sentinel sites, United States, June 2006-June 2009. MMWR 2010; 59:521-524.
19. Cortese MM, Tate JE, Simonsen L, et al. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatr Infect Dis J 2010; 29:489-494.
20. Atchison C, Edmunds J, Patel M, et al. Natural dynamics of mass rotavirus vaccination. Program and abstracts of the 9th International Rotavirus Symposium. Johannesburg, South Africa, 2010.
21. Pitzer VE, Viboud C, Simonsen L, et al. Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science 2009; 325:290-294.
22. Hull JJ, Teel EN, Kerin RK, et al. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J 2011; 30(Suppl 1):S42-S47.
23. Boom JA, Tate JE, Sahni LC, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010; 125:199-207.